A Study of the Androgen Receptor Gene Polymorphism and the Level of Expression of the Androgen Receptor in Androgenetic Alopecia Among Egyptians

    Hsh Kassem, RM Abou El Seoud, Ash Aly, H. A. Ibrahim, MA El Ramly
    Image of study
    TLDR The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.
    In 2009, a study involving 100 Egyptians, including 60 with androgenetic alopecia (AGA) and 40 controls, examined the androgen receptor (AR) gene polymorphism and AR expression levels in AGA. The study found that males with AGA had a higher incidence of the Stul cut allele in the AR gene compared to controls, with a borderline significance (p=0.07), and a significant association between the presence of the cut allele and higher grades of alopecia in both sexes. Immunohistochemical analysis revealed higher AR expression in bald scalp biopsies compared to non-bald areas, with a significant difference in staining intensity (p<0.0001). The study suggests that the Stul polymorphism in the AR gene may be associated with AGA, particularly in males, and that both high androgen levels and increased AR expression are required for baldness to occur. However, the association was not statistically significant in females (p=0.57), indicating that other genes and factors are likely involved in AGA. This was the first study to report such findings among Egyptians and points to the potential for genetic-based treatments for AGA, although currently, treatment efficacy is limited and emotional support is a key aspect of patient management.
    Discuss this study in the Community →

    Research cited in this study

    26 / 26 results

    Related Community Posts Join

    6 / 1000+ results

      community Maintaining hair until Breezula without Fin

      in Treatment  6 upvotes 4 years ago
      A 21-year-old male experienced side effects from topical finasteride and is seeking alternative treatments to maintain hair until Breezula is available. He is considering using minoxidil, Nizoral, micro-needling, and vitamin D supplementation, and may try CB or RU58841 if necessary.

      community Binding affinity of pyrilutamide!

      in Update  167 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community Hair loss causes are still a myth.

      in Chat  16 upvotes 3 years ago
      The conversation discusses the complexity of hair loss causes, suggesting that DHT sensitivity alone doesn't fully explain it. Treatments mentioned include finasteride and dutasteride.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  122 upvotes 1 year ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

    Related Research

    3 / 3 results